Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy

Cytokine

Volumn 47, Issue 1, 2009, Pages 37-42

  Tam, Frederick W K ^a   Riser, Bruce L ^b,c   Meeran, Karim ^a   Rambow, JoAnn ^b   Pusey, Charles D ^a   Frankel, Andrew H ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Chemokine; Diabetic nephropathy; Growth factor; MCP 1; Progression

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; HEMOGLOBIN A1C; MONOCYTE CHEMOTACTIC PROTEIN 1; RENIN INHIBITOR;

ADULT; AGED; ALBUMINURIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

ADULT; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHEMOKINE CCL2; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; YOUNG ADULT;

EID: 67549118453     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.04.001     Document Type: Article

References (27)

1. Furuta T., Saito T., Ootaka T., Soma J., Obara K., Abe K., et al. The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 21 (1993) 480-485
2. Young B.A., Johnson R.J., Alpers C.E., Eng E., Gordon K., Floege J., et al. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47 (1995) 935-944
3. Yoshimura T., and Leonard E.J. Human monocyte chemoattractant protein-1: structure and function. Cytokines 4 (1992) 131-152
4. Ha H., Yu M.R., Choi Y.J., Kitamura M., and Lee H.B. Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 13 (2002) 894-902
5. Yamagishi S., Inagaki Y., Okamoto T., Amano S., Koga K., Takeuchi M., et al. Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J Biol Chem 277 (2002) 20309-20315
6. Gu L., Hagiwara S., Fan Q., Tanimoto M., Kobata M., Yamashita M., et al. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes. Nephrol Dial Transplant 21 (2006) 299-313
7. Qi W., Chen X., Polhill T.S., Sumual S., Twigg S., Gilbert R.E., et al. TGF-beta1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway. Am J Physiol Renal Physiol 290 (2006) F703-F709
8. Mezzano S., Aros C., Droguett A., Burgos M.E., Ardiles L., Flores C., et al. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant 19 (2004) 2505-2512
9. Banba N., Nakamura T., Matsumura M., Kuroda H., and Hattori Y. Kasai K Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 58 (2000) 684-690
10. Morii T., Fujita H., Narita T., Shimotomai T., Fujishima H., Yoshioka N., et al. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J Diab Complications 17 (2003) 11-15
11. Chow F.Y., Nikolic-Paterson D.J., Ozols E., Atkins R.C., and Rollin B.J. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 69 (2006) 73-80
12. Murphy M., Godson C., Cannon S., Kato S., MacKenzie H.S., Martin F., et al. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274 (1999) 5830-5834
13. Twigg S.M., Cao Z., McLennan S.V., Burns W.C., Brammar G., Forbes J.M., et al. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology 143 (2002) 4907-4915
14. Riser B.L., DeNichilo M., Cortes P., Baker C., Grondin J.M., Yee J., et al. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 11 (2000) 25-38
15. Wahab N.A., Yevdokimova N., Weston B.S., Roberts T., Li X.J., Brinkman H., et al. Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J 359 (2001) 77-87
16. Riser B.L., Cortes P., DeNichilo M., Deshmukh P.V., Chahal P.S., Mohammed A.K., et al. Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report. Kidney Int 64 (2003) 451-458
17. Gilbert R.E., Akdeniz A., Weitz S., Usinger W.R., Molineaux C., Jones S.E., et al. Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy. Diab Care 26 (2003) 2632-2636
18. Nguyen T.Q., Tarnow L., Andersen S., Hovind P., Parving H.H., Goldschmeding R., et al. Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diab Care 29 (2006) 83-88
19. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
20. Tam F.W.K., Sanders J.-S., George A., Hammad T., Miller C., Dougan T., et al. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol Dial Transplant 19 (2004) 2761-2768
21. Cooker L.A., Peterson D., Rambow J., Riser M.L., Riser R.E., Najmabadi F., et al. TNF-alpha, but not IFN-gamma, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis. Am J Physiol Renal Physiol 293 (2007) F157-F165
22. Adler S.G., Kang S.W., Feld S., Cha D.R., Barba L., Striker L., et al. Can glomerular mRNAs in human type 1 diabetes be used to predict transition from normoalbuminuria to microalbuminuria?. Am J Kidney Dis 40 (2002) 184-188
23. Andersen S., van Nieuwenhoven F.A., Tarnow L., Rossing P., Rossing K., Wieten L., et al. Reduction of urinary connective tissue growth factor by losartan in type 1 patients with diabetic nephropathy. Kidney Int 67 (2005) 2325-2329
24. Kitagawa K., Wada T., Furuichi K., Hashimoto H., Ishiwata Y., Asano M., et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 165 (2004) 237-246
25. Wang Y., Rangan G.K., Tay Y.C., Wang Y., and Harris D.C. Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappaB in proximal tubule cells. J Am Soc Nephrol 10 (1999) 1204-1213
26. Wada T., Yokoyama H., Su S.B., Mukaida N., Iwano M., Dohi K., et al. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int 49 (1996) 761-767
27. Morcos M., Sayed A.A., Bierhaus A., Yard B., Waldherr R., Merz W., et al. Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 51 (2002) 3532-3544